The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 30, 2014
Filed:
Jul. 19, 2012
Applicants:
Mannching Sherry Ku, Thiells, NY (US);
Chih-kuang Chen, Taipei, TW;
Wei-shu LU, New Taipei, TW;
Chih-ming Chen, Taipei, TW;
I-yin Lin, Taipei, TW;
Inventors:
Mannching Sherry Ku, Thiells, NY (US);
Chih-Kuang Chen, Taipei, TW;
Wei-Shu Lu, New Taipei, TW;
Chih-Ming Chen, Taipei, TW;
I-Yin Lin, Taipei, TW;
Assignee:
TWi Biotechnology, Inc., Taipei, TW;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 37/02 (2006.01); A01N 37/10 (2006.01); A61K 31/225 (2006.01); C07C 50/18 (2006.01); A61K 45/06 (2006.01); A61K 38/17 (2006.01); A61K 31/235 (2006.01);
U.S. Cl.
CPC ...
A61K 31/235 (2013.01); A61K 45/06 (2013.01); A61K 38/1793 (2013.01); Y10S 514/866 (2013.01);
Abstract
Methods for treating abnormal glycosylated hemoglobin (HbA1c) levels in a patient in need thereof, wherein the provided methods comprise administering to a patient in need a therapeutically effective amount of an Interleukin-1β modulator. Also, the invention provides compositions comprising at least one lipid modifying agent and an IL-1β modulator.